Glucotrack (GCTK) Total Current Liabilities (2010 - 2026)

Glucotrack (GCTK) has reported Total Current Liabilities for 17 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities fell 3.14% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (down 3.14% YoY), and the FY2025 full-year result was $4.8 million, up 274.35% from the prior year.
• Total Current Liabilities fell to $3.0 million in Q2 2026 per GCTK's latest filing, from $4.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $5.3 million in Q3 2025 and bottomed at $916000.0 in Q1 2022.
• Historically, Total Current Liabilities has averaged $2.2 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities decreased 26.6% in 2022, then jumped 274.35% in 2025.
• Over 5 years, Total Current Liabilities stood at $1.0 million in 2022, then soared by 49.26% to $1.5 million in 2023, then dropped by 15.67% to $1.3 million in 2024, then surged by 274.35% to $4.8 million in 2025, then plunged by 37.4% to $3.0 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $3.0 million, $4.8 million, and $5.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.